As Novo Nordisk A/S and Eli Lilly and Co. go head-to-head in the U.S. and Chinese glucagon-like peptide-1 receptor agonists ...

Recently, the spotlight on weight management and metabolic health has intensified, partly due to the rise of GLP-1 (glucagon-like peptide-1) medications like Ozempic and Wegovy. These drugs, ...

As more people with type 2 diabetes (T2D) are taking medications to help manage blood sugar levels and weight loss, concerns ...

French researchers have developed a new drug delivery system that could cut the dosing schedule for the type 2 diabetes and ...

French researchers have developed a new drug delivery system that could cut the dosing schedule for type 2 diabetes and ...

If you were prescribed a GLP-1, it's important that you understand how your insurance coverage works in order to stay on top ...

GLP-1 stands for glucagon-like peptide 1, a class of injectable drugs originally intended for diabetes but now widely prescribed for weight loss. Novo Nordisk, the manufacturer of Ozempic and ...

Incretins are not just metabolic hormones that regulate glucose levels after eating. Their functions go beyond stimulating ...

to examine potential applications of glucagon-like peptide-1 receptor (GLP-1R) agonists in central nervous system disorders, such as dementia, Parkinson’s disease, substance and alcohol use disorders, ...

The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...